Literature DB >> 8547062

VLA-4 and VCAM-1 are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stromal cells.

R A Oostendorp1, G Reisbach, E Spitzer, K Thalmeier, H Dienemann, H G Mergenthaler, P Dörmer.   

Abstract

The molecular basis and functional significance of interactions between haemopoietic progenitor cells and the stromal microenvironment is still poorly understood. Here we investigated a broad panel of surface adhesion molecules for their involvement. For this purpose, the colony-forming capacity of stroma-adherent Bl-CEC, BFU-E and GM-CFC was studied. Both mononuclear bone marrow cells (BMC) and bone marrow-derived stromal cells (BMSC) express a wide variety of adhesion molecules. However, only antibodies against beta 1-, alpha 4-integrin (both chains of the very late activation antigen-4 (VLA-4)) and vascular cell adhesion molecule (VCAM-1) inhibited colony formation from stroma-adherent Bl-CFC by 50% or more. Antibodies against a panel of other adhesion molecules, including the alpha 5-integrin chain, were without effect. Subsequent pretreatment experiments revealed that VLA-4 on progenitors interacted with stromal VCAM-1. The inhibitory antibodies did not interfere with the clonogenic capacity of but with adhesion of BFU-E and GM-CFC. Whether the inhibitory antibodies act similarly on progenitors which depend on BMSC for growth and/or differentiation, such as BI-CFC, remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547062     DOI: 10.1111/j.1365-2141.1995.tb05290.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization.

Authors:  Melissa van Pel; Ronald van Os; Gerjo A Velders; Henny Hagoort; Peter M H Heegaard; Ivan J D Lindley; Roel Willemze; Willem E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin.

Authors:  S H Lang; N W Clarke; N J George; N G Testa
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 3.  Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.

Authors:  Jochen G Schneider; Sarah R Amend; Katherine N Weilbaecher
Journal:  Bone       Date:  2010-09-17       Impact factor: 4.398

4.  Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells.

Authors:  Sachin Malhotra; Paul W Kincade
Journal:  Exp Hematol       Date:  2008-10-25       Impact factor: 3.084

5.  Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements.

Authors:  Michael J McClellan; Sarika Khasnis; C David Wood; Richard D Palermo; Sandra N Schlick; Aditi S Kanhere; Richard G Jenner; Michelle J West
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

6.  Hematopoietic stem and progenitor cells as effectors in innate immunity.

Authors:  Jennifer L Granick; Scott I Simon; Dori L Borjesson
Journal:  Bone Marrow Res       Date:  2012-06-19

7.  Expression of adhesion molecules on CD34+ cells from steady-state bone marrow before and after mobilization and their association with the yield of CD34+ cells.

Authors:  Karin Zattar Cecyn; Eliza Y S Kimura; Dulce Marta S M Lima; Miyoko Yamamoto; José Orlando Bordin; José Salvador R de Oliveira
Journal:  Blood Res       Date:  2018-03-27

Review 8.  Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.

Authors:  Jian Chen; Hillard M Lazarus; Parastoo B Dahi; Scott Avecilla; Sergio A Giralt
Journal:  Blood Rev       Date:  2020-10-31       Impact factor: 10.626

9.  Amelioration of cyclophosphamide-induced myelosuppression during treatment to rats with breast cancer through low-intensity pulsed ultrasound.

Authors:  Wei Wang; Dong Luo; Junlin Chen; Jinyun Chen; Yi Xia; Wenzhi Chen; Yan Wang
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.